Skip to main content

lung cancer Archives

Lung cancer study reveals new drug combination targets

Sep. 4, 2014—A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

Read more


Low selenium and lung cancer

Aug. 6, 2014—Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.

Read more


Lovly’s research bolstered by lung cancer foundation

Jul. 17, 2014—The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.

Read more


Rising tobacco epidemic in Asia linked to elevated risk of death

Jun. 9, 2014—A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll.

Read more


Study tracks new lung cancer drug target

Apr. 10, 2014—Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.

Read more


New direction for treating lung cancer

Feb. 7, 2014—Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Read more


VICC debuts lung cancer screening program

Jan. 30, 2014—Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans.

Read more


Probing mutant EGF receptor regulation

Oct. 10, 2013—Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

Read more


VU study identifies DNA changes in drug-resistant cancer cells

Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

Read more


Study explores race differences of lung cancer risk

Aug. 1, 2013—Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups.

Read more


Study finds state-to-state variation in benign lung disease diagnosis

May. 30, 2013—A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.

Read more


Study finds high soy diet before lung cancer diagnosis improves survival

Mar. 26, 2013—A new study by researchers at Vanderbilt University Medical Center and the Shanghai Cancer Institute found women who ate more soy food prior to a diagnosis of lung cancer lived longer than those who consumed less. The study, conducted in Shanghai, China, was published in the March 25 issue of the Journal of Clinical Oncology.

Read more


Page 3 of 512345

Upcoming Events

MORE EVENTS »